Collective Intelligence

The first interactive platform that brings together innovation players around common interest.

EMA gave the green light to 89 innovative medicines in 2022

In 2022, the European Medicines Agency (EMA) recommended 89 medicines for marketing authorization: including six advanced therapy medicinal products and eight biosimilars.

Our comment :

Access to market for new medicines is essential to advancing public health as they bring new opportunities for patients. Among the 89 medicines, 41 contain new active substance. Some of them represent significant progress in their therapeutic areas, 3 being recommanded for use outside the EU.
Geraldine Andrieux, CEO and Founder
ClosePlease login

EMA gave the green light to 89 innovative medicines in 2022

In 2022, the European Medicines Agency (EMA) recommended 89 medicines for marketing authorization: including six advanced therapy medicinal products and eight biosimilars.

BLUMORPHO comment :

Access to market for new medicines is essential to advancing public health as they bring new opportunities for patients. Among the 89 medicines, 41 contain new active substance. Some of them represent significant progress in their therapeutic areas, 3 being recommanded for use outside the EU.
Geraldine Andrieux, CEO and Founder
ClosePlease login

EMA gave the green light to 89 innovative medicines in 2022

In 2022, the European Medicines Agency (EMA) recommended 89 medicines for marketing authorization: including six advanced therapy medicinal products and eight biosimilars.

BLUMORPHO comment :

Access to market for new medicines is essential to advancing public health as they bring new opportunities for patients. Among the 89 medicines, 41 contain new active substance. Some of them represent significant progress in their therapeutic areas, 3 being recommanded for use outside the EU.
Geraldine Andrieux, CEO and Founder
ClosePlease login
ClosePlease login
ClosePlease login
ClosePlease login
ClosePlease login
ClosePlease login

Our previous articles

ClosePlease login